SmartCells
Beverly
About SmartCells
SmartCells, Inc. designs and develops insulin products. It offers SmartInsulin, a self regulating injectable formulation for treating diabetes. The company's polymer-based dosing technology is used for various applications, such as fertility, thyroid, and growth hormone deficiencies; treatments with poor compliance or therapeutic window issues, such as oncology; and drug-device combinations. SmartCells, Inc. was founded in 2003 and is based in Beverly, Massachusetts.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $13.0M
- Funding stage: M&A
- Last round: Series D (Jun 2010)
- Website: smartinsulin.com
- Phone: 978.927.4246
Industries & Categories
Biotechnology, Diabetes, Health Care, Therapeutics
Canonical: https://fsome.com/organization/smartcells-2918230 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.